Comparative cost analysis of generalized anxiety disorder and major depressive disorder patients in secondary care from a national hospital registry in Finland

References

• Wittchen HU, Zhao S, Kessler RC, Eaton WW. DSM-III-R generalized anxiety disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1994 ;51:355–64.
   PubMed Web of Science ®Google Scholar
• Wittchen HU, Hoyer J. Generalized anxiety disorder: Nature and course. J Clin Psychiatry 2001 discussion 20-1;62 Suppl 11:15–19.
   PubMed Web of Science ®Google Scholar
• Maier W, Gansicke M, Freyberger HJ, Linz M, Heun R, Lecrubier Y. Generalized anxiety disorder (ICD-10) in primary care from a cross-cultural perspective: A valid diagnostic entity?. Acta Psychiatr Scand 2000;101:29–36.
   PubMed Web of Science ®Google Scholar
• Rodriguez BF, Weisberg RB, Pagano ME, Bruce SE, Spencer MA, Culpepper L, et al. Characteristics and predictors of full and partial recovery from generalized anxiety disorder in primary care patients. J Nerv Ment Dis 2006;194:91–7.
   PubMed Web of Science ®Google Scholar
• Hoffman DL, Dukes EM, Wittchen HU. Human and economic burden of generalized anxiety disorder. Depress Anxiety 2008;25:72–90.
   PubMed Web of Science ®Google Scholar
• Judd LL, Kessler RC, Paulus MP, Zeller PV, Wittchen HU, Kunovac JL. Comorbidity as a fundamental feature of generalized anxiety disorders: Results from the National Comorbidity Study (NCS). Acta Psychiatr Scand Suppl 1998;393 Suppl 393:6–11.
   PubMedGoogle Scholar
• Wittchen HU, Carter RM, Pfister H, Montgomery SA, Kessler RC. Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey. Int Clin Psychopharmacol 2000;15:319–28.
   PubMed Web of Science ®Google Scholar
• Mittal D, Fortney JC, Pyne JM, Edlund MJ, Wetherell JL. Impact of comorbid anxiety disorders on health-related quality of life among patients with major depressive disorder. Psychiatr Serv 2006;57:1731–7.
   PubMed Web of Science ®Google Scholar
• Cairney J, Corna LM, Veldhuizen S, Herrmann N, Streiner DL. Comorbid depression and anxiety in later life: Patterns of association, subjective well-being, and impairment. Am J Geriatr Psychiatry 2008;16:201–8.
   PubMed Web of Science ®Google Scholar
• Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2013;380:2197–223.
   Web of Science ®Google Scholar
• Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jonsson B, et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011;21:655–79.
   PubMed Web of Science ®Google Scholar
• Ustun TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJ. Global burden of depressive disorders in the year 2000. Br J Psychiatry 2004;184:386–92.
   PubMed Web of Science ®Google Scholar
• Luppa M, Heinrich S, Angermeyer MC, Konig HH, Riedel-Heller SG. Cost-of-illness studies of depression: A systematic review. J Affect Disord 2007;98:29–43.
   PubMed Web of Science ®Google Scholar
• Greenberg PE, Birnbaum HG. The economic burden of depression in the US: Societal and patient perspectives. Expert Opin Pharmacother 2005;6:369–76.
   PubMed Web of Science ®Google Scholar
• Olesen J, Gustavsson A, Svensson M, Wittchen HU, Jonsson B, CDBE2010 study g, et al. The economic cost of brain disorders in Europe. Eur J Neurol 2012;19:155–62.
   PubMed Web of Science ®Google Scholar
• Konnopka A, Leichsenring F, Leibing E, Konig HH. Cost-of-illness studies and cost-effectiveness analyses in anxiety disorders: A systematic review. J Affect Disord 2009;114:14–31.
   PubMed Web of Science ®Google Scholar
• Linna M, Hakkinen U, Peltola M, Magnussen J, Anthun KS, Kittelsen S, et al. Measuring cost efficiency in the Nordic hospitals—A cross-sectional comparison of public hospitals in 2002. Health Care Manag Sci 2010;13:346–57.
   PubMed Web of Science ®Google Scholar
• Culpepper L. Generalized anxiety disorder and medical illness. J Clin Psychiatry 2009;70 Suppl 2:20–4.
   PubMed Web of Science ®Google Scholar
• Andlin-Sobocki P, Jonsson B, Wittchen HU, Olesen J. Cost of disorders of the brain in Europe. Eur J Neurol 2005;12 Suppl 1: 1–27.
   PubMed Web of Science ®Google Scholar
• Greenberg PE, Sisitsky T, Kessler RC, Finkelstein SN, Berndt ER, Davidson JR, et al. The economic burden of anxiety disorders in the 1990s. J Clin Psychiatry 1999 ;60:427–35.
   PubMed Web of Science ®Google Scholar
• Smit F, Cuijpers P, Oostenbrink J, Batelaan N, de Graaf R, Beekman A. Costs of nine common mental disorders: Implications for curative and preventive psychiatry. J Ment Health Policy Econ 2006;9:193–200.
   PubMed Web of Science ®Google Scholar
• Souetre E, Lozet H, Cimarosti I, Martin P, Chignon JM, Ades J, et al. Cost of anxiety disorders: Impact of comorbidity. J Psychosom Res 1994;38 Suppl 1:151–60.
   PubMed Web of Science ®Google Scholar
• Wittchen HU, Kessler RC, Beesdo K, Krause P, Hofler M, Hoyer J. Generalized anxiety and depression in primary care: Prevalence, recognition, and management. J Clin Psychiatry 2002;63 Suppl 8:24–34.
   PubMed Web of Science ®Google Scholar
• Baldwin D, Woods R, Lawson R, Taylor D. Efficacy of drug treatments for generalised anxiety disorder: Systematic review and meta-analysis. BMJ 2011;342:1199.
   PubMed Web of Science ®Google Scholar
• Furukawa TA. Drug treatment for generalised anxiety disorder. BMJ 2011;342:1216.
   Google Scholar
• Kendall T, Cape J, Chan M, Taylor C, Guideline Development G. Management of generalised anxiety disorder in adults: Summary of NICE guidance. BMJ 2011;342:7460.
   Google Scholar
• National Collaborating Centre for Mental Health Commissioned by the National Institute for Health and Clinical Excellence. Common mental health disorders: Identification and pathways to care. National Clinical Guideline Number 123. 2011;123.
   Google Scholar